ACP
GHDX

Acuta Capital Partners’s Genomic Health, Inc. GHDX Stock Holding History

Acuta Capital Partners’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-72,100
Closed -$2.08M – 73
2016
Q3 		$2.08M Buy
72,100
+23,300
+48% +$649K 0.78% 36
2016
Q2 		$1.26M Buy
+48,800
New +$1.3M 0.61% 41

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Acuta Capital Partners's GHDX Position: Q4 2016 in Review

Acuta Capital Partners sold out of Genomic Health, Inc. (GHDX) in Q4 2016, closing a stake of 72,100 shares — an estimated $2.08M sold.

Acuta Capital Partners first reported a position in GHDX in Q2 2016 and held it in 2 quarters. The position peaked at $2.08M in Q3 2016. 133 funds tracked by Wall St. Rank hold GHDX as of Q4 2016.

  • Acuta Capital Partners reported no remaining Genomic Health, Inc. position as of Q4 2016 after selling out during the quarter.
  • Acuta Capital Partners sold 72,100 Genomic Health, Inc. shares in Q4 2016, an estimated $2.08M.
  • Acuta Capital Partners first reported a position in Genomic Health, Inc. in Q2 2016 and held it in 2 quarters.
  • Acuta Capital Partners's Genomic Health, Inc. position peaked at $2.08M in Q3 2016.
  • 133 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2016.

Based on Acuta Capital Partners's 13F filing for Q4 2016, filed 13 Feb 2017.